Terumo Cardiovascular Systems Corporation
USPTO PatentsView assignee record - 49 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Terumo ranks #6,849 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 26 technology areas.
- #6,849
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (46.1/100)
- 13.2
- avg claims per patent
- +30%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6849 · US Corporation #6,849 · 49 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 49 grants
- UPPER-Q #6,849/49,997
- PHOTO-FINISH Spigen
- CPC-FOCUS A61B · 26 areas
- INNOV-PAR 46.1/100
- CLAIMS-RICH 13.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +30% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Spigen, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Terumo’s 46.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Terumo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AIT Austrian… · near
AIT Austrian… · near
46 score
- Biocompatibles UK · near
Biocompatibles UK · near
46 score
- Saint-gobain… · near
Saint-gobain… · near
46 score
- Terumo Cardiovascula… · this assignee
Terumo Cardiovascula… · this assignee
46 score
- eMoMo Technology · near
eMoMo Technology · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Terumo's Innovation Score is 46.1/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Terumo?
Each dot is one of Terumo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Terumo’s own 13.2 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Terumo's grants concentrate
Terumo Cardiovascular Systems Corporation is a focused PatentsView assignee: 26 CPC subclasses with 53.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2016. By volume, Terumo sits between Spigen, Inc. and Ultratech.
Terumo's three-year grant acceleration
Terumo Cardiovascular Systems Corporation shows 17 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Terumo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Spigen
Spigen, Inc.
49 patents
- Stubhub
StubHub, Inc.
49 patents
- TCL Technology Gr…
TCL Technology Group Corporation
49 patents
- THE Wiremold
THE Wiremold Company
49 patents
- Tyco AMP Korea
Tyco Electronics AMP Korea Co., Ltd.
49 patents
- University Public…
University Public Corporation Osaka
49 patents
- UniversitÉ Cathol…
UNIVERSITÉ Catholique DE Louvain
49 patents
- Ultratech
Ultratech
49 patents
- Terumo Cardiovasc… ◀
Terumo Cardiovascular Systems Corporation
49 patents
What this shows Terumo holds 49 patents at rank #6,850, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Terumo
By rank, the assignees closest to #6,850 in granted patent volume.
- Spigen, Inc. #6,846 · 49 patents
- StubHub, Inc. #6,847 · 49 patents
- TCL Technology Group Corporation #6,848 · 49 patents
- THE Wiremold Company #6,849 · 49 patents
- Tyco Electronics AMP Korea Co., Ltd. #6,851 · 49 patents
- University Public Corporation Osaka #6,852 · 49 patents
- UNIVERSITÉ Catholique DE Louvain #6,853 · 49 patents
- Ultratech #6,854 · 49 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Terumo's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Terumo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Terumo ranks #709 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Terumo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 6.1% |
| 2016 | 2 | 4.1% |
| 2017 | 2 | 4.1% |
| 2018 | 5 | 10.2% |
| 2019 | 8 | 16.3% |
| 2020 | 2 | 4.1% |
| 2021 | 7 | 14.3% |
| 2022 | 5 | 10.2% |
| 2023 | 4 | 8.2% |
| 2024 | 8 | 16.3% |
| 2025partial year | 3 | 6.1% |
Which technologies does Terumo Cardiovascular Systems Corporation patent most?
Top 15 of 26 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Terumo Cardiovascular Systems Corporation's patent record in context - here's where to go next.
- Terumo Cardiovascular Systems Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 53.1% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #6,849 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Terumo Cardiovascular Systems Corporation against Spigen, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.